Comparison of Clinical Characteristics and Prognostic Laboratory Findings of COVID-19 Patients by Age Groups

O. Eren-Kutsoylu, A. Nazli-Zeka, Gokcen Omeroglu-Simsek, Ozgur Appak, B. Bayram, Aylin Ozgen-Alpaydın, Nese Colak-Oray, N. Yapar, V. Avkan-Oğuz
{"title":"Comparison of Clinical Characteristics and Prognostic Laboratory Findings of COVID-19 Patients by Age Groups","authors":"O. Eren-Kutsoylu, A. Nazli-Zeka, Gokcen Omeroglu-Simsek, Ozgur Appak, B. Bayram, Aylin Ozgen-Alpaydın, Nese Colak-Oray, N. Yapar, V. Avkan-Oğuz","doi":"10.36519/idcm.2021.76","DOIUrl":null,"url":null,"abstract":"Objective: In this study, we determined the symptoms of the COVID-19 and defined agespecific symptoms that can help diagnose the disease on hospital admission. Materials and Methods: Patients who visited a university hospital’s adult pandemia outpatient clinic with suspected COVID-19 symptoms and tested with SARS-CoV-2 polymerase chain reaction test between March 17 – May 17, 2020, were included in the study. Demographic data, symptoms on admission, prognostic laboratory tests and hospitalization were recorded. Results: Out of 5289 admissions, 639 (12.1%) patients had suspected or confirmed COVID-19. Patients were sorted incident to age groups to determine the difference in demographic data, comorbidities, symptoms, prognostic laboratory findings and outcome. The exposure history was lower in the 65-79 age group, contrary to the ≥ 80 age group. Sore throat, loss of smell and taste, headache and myalgia were specific to the 18-49 age group (p<0.001). Shortness of breath was represented 2.31 and 2.79 times higher in the 65-79 and the ≥ 80 age group, respectively, than the 18-49 age group. Comorbid diseases, prognostic laboratory tests (lymphopenia, C-reactive protein (CRP), D-dimer, ferritin) and hospitalization were found significantly higher in the ≥ 65 age group than the 18-49 age group. Conclusion: This study identifies the varieties in comorbidities, symptoms, prognostic laboratory findings and outcomes between the age-grouped patients referred to the outpatient clinic with suspected or confirmed COVID-19. We found that comorbidities, poor prognostic factors and hospitalization are more common in patients over 65 years. Shortness of breath is the most common symptom seen in the ≥ 65 age group compared to the 18-49 age group, where sore throat, loss of taste and smell are the symptoms commonly seen. Predominant symptoms for age groups help physicians differentiate the disease in clinical practice.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"61 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology and Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36519/idcm.2021.76","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: In this study, we determined the symptoms of the COVID-19 and defined agespecific symptoms that can help diagnose the disease on hospital admission. Materials and Methods: Patients who visited a university hospital’s adult pandemia outpatient clinic with suspected COVID-19 symptoms and tested with SARS-CoV-2 polymerase chain reaction test between March 17 – May 17, 2020, were included in the study. Demographic data, symptoms on admission, prognostic laboratory tests and hospitalization were recorded. Results: Out of 5289 admissions, 639 (12.1%) patients had suspected or confirmed COVID-19. Patients were sorted incident to age groups to determine the difference in demographic data, comorbidities, symptoms, prognostic laboratory findings and outcome. The exposure history was lower in the 65-79 age group, contrary to the ≥ 80 age group. Sore throat, loss of smell and taste, headache and myalgia were specific to the 18-49 age group (p<0.001). Shortness of breath was represented 2.31 and 2.79 times higher in the 65-79 and the ≥ 80 age group, respectively, than the 18-49 age group. Comorbid diseases, prognostic laboratory tests (lymphopenia, C-reactive protein (CRP), D-dimer, ferritin) and hospitalization were found significantly higher in the ≥ 65 age group than the 18-49 age group. Conclusion: This study identifies the varieties in comorbidities, symptoms, prognostic laboratory findings and outcomes between the age-grouped patients referred to the outpatient clinic with suspected or confirmed COVID-19. We found that comorbidities, poor prognostic factors and hospitalization are more common in patients over 65 years. Shortness of breath is the most common symptom seen in the ≥ 65 age group compared to the 18-49 age group, where sore throat, loss of taste and smell are the symptoms commonly seen. Predominant symptoms for age groups help physicians differentiate the disease in clinical practice.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
不同年龄组COVID-19患者临床特征及预后实验室结果的比较
目的:在本研究中,我们确定了COVID-19的症状,并定义了可以帮助住院诊断疾病的年龄特异性症状。材料与方法:选取2020年3月17日至5月17日在某大学医院成人大流行门诊就诊并进行SARS-CoV-2聚合酶链反应检测的疑似COVID-19症状患者为研究对象。记录人口统计数据、入院时的症状、预后实验室检查和住院情况。结果:在5289例入院患者中,有639例(12.1%)患者疑似或确诊COVID-19。将患者按年龄组分类,以确定人口学数据、合并症、症状、预后实验室结果和结果的差异。65 ~ 79岁年龄组暴露史较低,与≥80岁年龄组相反。喉咙痛、嗅觉和味觉丧失、头痛和肌痛是18-49岁年龄组所特有的(p<0.001)。65-79岁和≥80岁年龄组的呼吸短促分别是18-49岁年龄组的2.31倍和2.79倍。共病、预后实验室检查(淋巴细胞减少、c反应蛋白(CRP)、d -二聚体、铁蛋白)和住院率在≥65岁年龄组明显高于18-49岁年龄组。结论:本研究确定了到门诊就诊的疑似或确诊COVID-19患者在合并症、症状、预后实验室检查结果和结局方面的差异。我们发现合并症、预后不良因素和住院治疗在65岁以上的患者中更为常见。呼吸短促是≥65岁年龄组最常见的症状,而18-49岁年龄组最常见的症状是喉咙痛、味觉和嗅觉丧失。各年龄组的主要症状有助于医生在临床实践中区分疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparison of 28-Day Mortality Between Hospital- and Community-Acquired Influenza Patients Long-Term Symptoms and Quality of Life in Persons with COVID-19 B Cell Subtypes in Individuals Received mRNA or Inactivated Vaccine Boosters After Fully Vaccinated with CoronaVac: A Longitudinal Study Centenary of the Republic and 90th Anniversary of the University Reform in Türkiye COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1